魯西化工(000830.SZ):擬投資建設年產120萬噸雙酚A項目一期工程
格隆匯11月16日丨魯西化工(000830.SZ)公佈,2021年11月16日,公司召開了第八屆董事會第十九次會議,審議通過了《關於投資建設年產120萬噸雙酚A項目一期工程的議案》,結合公司產品結構和市場發展趨勢,公司擬投資建設年產120萬噸雙酚A項目一期工程,進一步延鏈、補鏈、強鏈,不斷提升公司的競爭力和綜合實力。
該項目建設內容主要包括:20萬噸雙酚A項目及配套公用工程等輔助設施。一期工程預計總投資7.9億元,項目建設使用的貨幣資金,主要通過企業自籌和銀行貸款等方式,確保項目建設順利實施。
該項目預計2022年建成投產,可新增20萬噸雙酚A產品,滿足公司的聚碳酸酯裝置生產使用。項目投產後預計年可實現營業收入28億元,利税3.8億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.